Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $258.10 million. The enterprise value is $66.98 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ALLO has 218.73 million shares outstanding. The number of shares has increased by 26.55% in one year.
Current Share Class | 218.73M |
Shares Outstanding | 218.73M |
Shares Change (YoY) | +26.55% |
Shares Change (QoQ) | +2.27% |
Owned by Insiders (%) | 8.98% |
Owned by Institutions (%) | 71.74% |
Float | 157.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 25,304.15 |
PB Ratio | 0.68 |
P/TBV Ratio | 0.67 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.23.
Current Ratio | 9.71 |
Quick Ratio | 9.40 |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -764.86 |
Financial Efficiency
Return on equity (ROE) is -59.60% and return on invested capital (ROIC) is -30.68%.
Return on Equity (ROE) | -59.60% |
Return on Assets (ROA) | -28.92% |
Return on Invested Capital (ROIC) | -30.68% |
Return on Capital Employed (ROCE) | -52.97% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.10M |
Employee Count | 229 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
Income Tax | 443,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.57% in the last 52 weeks. The beta is 0.31, so ALLO's price volatility has been lower than the market average.
Beta (5Y) | 0.31 |
52-Week Price Change | -49.57% |
50-Day Moving Average | 1.31 |
200-Day Moving Average | 1.97 |
Relative Strength Index (RSI) | 40.77 |
Average Volume (20 Days) | 2,688,386 |
Short Selling Information
The latest short interest is 26.04 million, so 11.91% of the outstanding shares have been sold short.
Short Interest | 26.04M |
Short Previous Month | 24.57M |
Short % of Shares Out | 11.91% |
Short % of Float | 16.57% |
Short Ratio (days to cover) | 7.91 |
Income Statement
Revenue | n/a |
Gross Profit | -190.24M |
Operating Income | -253.17M |
Pretax Income | -251.88M |
Net Income | -252.32M |
EBITDA | -239.99M |
EBIT | -253.17M |
Earnings Per Share (EPS) | -$1.22 |
Full Income Statement Balance Sheet
The company has $280.04 million in cash and $88.92 million in debt, giving a net cash position of $191.12 million or $0.87 per share.
Cash & Cash Equivalents | 280.04M |
Total Debt | 88.92M |
Net Cash | 191.12M |
Net Cash Per Share | $0.87 |
Equity (Book Value) | 385.39M |
Book Value Per Share | 1.76 |
Working Capital | 261.55M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$197.33 million and capital expenditures -$785,000, giving a free cash flow of -$198.12 million.
Operating Cash Flow | -197.33M |
Capital Expenditures | -785,000 |
Free Cash Flow | -198.12M |
FCF Per Share | -$0.91 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.55% |
Shareholder Yield | -26.55% |
Earnings Yield | -97.76% |
FCF Yield | -76.76% |
Analyst Forecast
The average price target for ALLO is $8.44, which is 615.25% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.44 |
Price Target Difference | 615.25% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | 608.29% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -3.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.72 |
Piotroski F-Score | 1 |